Form D Explorer

Form 1-K — Nok Therapeutics, Inc.

0001213900-26-050128 · filed 2026-04-30

Offering

Total offering
Total sold
Security type
Price per security
Over-allotment
Jurisdictions

Issuer

CIK
2038166
Entity
Corporation
Jurisdiction
FLORIDA
Address
2009 MACKENZIE WAY
CRANBERRY TWP., PA 16066

Most recent fiscal year financials

Reg A+ Tier 2 financials are audited (1-A, 1-K). Tier 1 are reviewed.

Total assets
Total liabilities
Cash
Total revenues
Net income

Same issuer's Form D filings

View original on SEC EDGAR.